These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 22223728)

  • 1. Regulatory T-cell response to apolipoprotein B100-derived peptides reduces the development and progression of atherosclerosis in mice.
    Herbin O; Ait-Oufella H; Yu W; Fredrikson GN; Aubier B; Perez N; Barateau V; Nilsson J; Tedgui A; Mallat Z
    Arterioscler Thromb Vasc Biol; 2012 Mar; 32(3):605-12. PubMed ID: 22223728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The intravenous injection of oxidized LDL- or Apolipoprotein B100--Coupled splenocytes promotes Th1 polarization in wildtype and Apolipoprotein E--Deficient mice.
    Steinmetz M; Ponnuswamy P; Laurans L; Esposito B; Tedgui A; Mallat Z
    Biochem Biophys Res Commun; 2015 Aug; 464(1):306-11. PubMed ID: 26116775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasal immunization with an apolipoprotein B-100 fusion protein induces antigen-specific regulatory T cells and reduces atherosclerosis.
    Klingenberg R; Lebens M; Hermansson A; Fredrikson GN; Strodthoff D; Rudling M; Ketelhuth DF; Gerdes N; Holmgren J; Nilsson J; Hansson GK
    Arterioscler Thromb Vasc Biol; 2010 May; 30(5):946-52. PubMed ID: 20167655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral FTY720 administration induces immune tolerance and inhibits early development of atherosclerosis in apolipoprotein E-deficient mice.
    Huang K; Li SQ; Wang WJ; Liu LS; Jiang YG; Feng PN; Wang YQ; Wang SM
    Int J Immunopathol Pharmacol; 2012; 25(2):397-406. PubMed ID: 22697071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral administration of recombinant Mycobacterium smegmatis expressing a tripeptide construct derived from endogenous and microbial antigens prevents atherosclerosis in ApoE(-/-) mice.
    Deshpande V; Krishnan R; Philip S; Faludi I; Ponnusamy T; Thota LN; Endresz V; Lu X; Kakkar VV; Mundkur LA
    Cardiovasc Ther; 2016 Oct; 34(5):314-24. PubMed ID: 27241889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory CD4
    Kimura T; Kobiyama K; Winkels H; Tse K; Miller J; Vassallo M; Wolf D; Ryden C; Orecchioni M; Dileepan T; Jenkins MK; James EA; Kwok WW; Hanna DB; Kaplan RC; Strickler HD; Durkin HG; Kassaye SG; Karim R; Tien PC; Landay AL; Gange SJ; Sidney J; Sette A; Ley K
    Circulation; 2018 Sep; 138(11):1130-1143. PubMed ID: 29588316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smooth Muscle Cell-Derived Interleukin-17C Plays an Atherogenic Role via the Recruitment of Proinflammatory Interleukin-17A+ T Cells to the Aorta.
    Butcher MJ; Waseem TC; Galkina EV
    Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1496-506. PubMed ID: 27365405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of oral tolerance to HSP60 or an HSP60-peptide activates T cell regulation and reduces atherosclerosis.
    van Puijvelde GH; van Es T; van Wanrooij EJ; Habets KL; de Vos P; van der Zee R; van Eden W; van Berkel TJ; Kuiper J
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2677-83. PubMed ID: 17901374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TSLPR deficiency attenuates atherosclerotic lesion development associated with the inhibition of TH17 cells and the promotion of regulator T cells in ApoE-deficient mice.
    Wu C; He S; Peng Y; Kushwaha KK; Lin J; Dong J; Wang B; Lin J; Shan S; Liu J; Huang K; Li D
    J Mol Cell Cardiol; 2014 Nov; 76():33-45. PubMed ID: 25117469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination against T-cell epitopes of native ApoB100 reduces vascular inflammation and disease in a humanized mouse model of atherosclerosis.
    Gisterå A; Hermansson A; Strodthoff D; Klement ML; Hedin U; Fredrikson GN; Nilsson J; Hansson GK; Ketelhuth DF
    J Intern Med; 2017 Apr; 281(4):383-397. PubMed ID: 28194913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-155 deficiency results in decreased macrophage inflammation and attenuated atherogenesis in apolipoprotein E-deficient mice.
    Du F; Yu F; Wang Y; Hui Y; Carnevale K; Fu M; Lu H; Fan D
    Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):759-67. PubMed ID: 24504735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of HLA-A2 restricted CD8 T cell responses against ApoB100 peptides does not affect atherosclerosis in a humanized mouse model.
    Schaftenaar FH; Amersfoort J; Douna H; Kröner MJ; Foks AC; Bot I; Slütter BA; van Puijvelde GHM; Drijfhout JW; Kuiper J
    Sci Rep; 2019 Nov; 9(1):17391. PubMed ID: 31757993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of a regulatory T cell type 1 response reduces the development of atherosclerosis in apolipoprotein E-knockout mice.
    Mallat Z; Gojova A; Brun V; Esposito B; Fournier N; Cottrez F; Tedgui A; Groux H
    Circulation; 2003 Sep; 108(10):1232-7. PubMed ID: 12912803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune responses elicited by apoB-100-derived peptides in mice.
    Pierides C; Bermudez-Fajardo A; Fredrikson GN; Nilsson J; Oviedo-Orta E
    Immunol Res; 2013 May; 56(1):96-108. PubMed ID: 23345063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defective leptin/leptin receptor signaling improves regulatory T cell immune response and protects mice from atherosclerosis.
    Taleb S; Herbin O; Ait-Oufella H; Verreth W; Gourdy P; Barateau V; Merval R; Esposito B; Clément K; Holvoet P; Tedgui A; Mallat Z
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2691-8. PubMed ID: 17690315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune regulation by oral tolerance induces alternate activation of macrophages and reduces markers of plaque destabilization in Apob
    Thota LN; Ponnusamy T; Philip S; Lu X; Mundkur L
    Sci Rep; 2017 Jun; 7(1):3997. PubMed ID: 28638138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucosal tolerance to a combination of ApoB and HSP60 peptides controls plaque progression and stabilizes vulnerable plaque in Apob(tm2Sgy)Ldlr(tm1Her)/J mice.
    Mundkur L; Mukhopadhyay R; Samson S; Varma M; Kale D; Chen D; Shivaprasad S; Sivanandan H; Soman V; Lu X; Kakkar VV
    PLoS One; 2013; 8(3):e58364. PubMed ID: 23505495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenic Autoimmunity in Atherosclerosis Evolves From Initially Protective Apolipoprotein B
    Wolf D; Gerhardt T; Winkels H; Michel NA; Pramod AB; Ghosheh Y; Brunel S; Buscher K; Miller J; McArdle S; Baas L; Kobiyama K; Vassallo M; Ehinger E; Dileepan T; Ali A; Schell M; Mikulski Z; Sidler D; Kimura T; Sheng X; Horstmann H; Hansen S; Mitre LS; Stachon P; Hilgendorf I; Gaddis DE; Hedrick C; Benedict CA; Peters B; Zirlik A; Sette A; Ley K
    Circulation; 2020 Sep; 142(13):1279-1293. PubMed ID: 32703007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An ApoB100-mimetic vaccine prevents obesity and liver steatosis in ApoE-/- mice.
    Kong SK; Choe MK; Kim HJ; Kim YS; Binas B; Kim HJ
    Pharmacol Rep; 2017 Dec; 69(6):1140-1144. PubMed ID: 29128792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acceleratory effects of ambient fine particulate matter on the development and progression of atherosclerosis in apolipoprotein E knockout mice by down-regulating CD4
    Wan Q; Liu Z; Yang M; Wu J
    Toxicol Lett; 2019 Nov; 316():27-34. PubMed ID: 31513887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.